News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

National Neurovision Research Institute (NNRI) and Resolvyx Pharmaceuticals, Inc. Collaborate to Assess Resolvins to Treat Degenerative Eye Diseases


11/20/2008 9:58:07 AM

OWINGS MILLS, Md. & BEDFORD, Mass.--(BUSINESS WIRE)--National Neurovision Research Institute (NNRI), a research support organization for the Foundation Fighting Blindness and the leading non-government funding source for inherited orphan retinal degeneration research, and Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced a research collaboration whereby NNRI will fully fund preclinical studies to evaluate the potential of novel resolvin therapeutics for eye diseases of the retina that lack current treatments, specifically genetic retinal degenerative diseases and dry age-related macular degeneration (AMD).

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES